Patients with advanced germ cell tumors can be cured with cisplatin-based chemotherapy but the outcome remains unsatisfactory for patients with relapsed disease. Targeted therapies have changed the standard of care for many advanced solid tumors.
Hannover Medical School, Department of Hematology, Hemostaseology, Oncology and Stem Cell Transplantation, Carl-Neuberg-Strasse 1, 30625 Hannover, Germany. fenner.martin@mh-hannover.de